Chemical Compound

3-(5-tert-butyl-1,2-oxazol-3-yl)-1-(4-(10-(2-(morpholin-4-yl)ethoxy)-7-thia-2,5-diazatricyclo(6.4.0.0^(2,6))dodeca-1(12),3,5,8,10-pentaen-4-yl)phenyl)urea

CAS Registry Number 950769-58-1
返回搜索 申请报价
3-(5-tert-butyl-1,2-oxazol-3-yl)-1-(4-(10-(2-(morpholin-4-yl)ethoxy)-7-thia-2,5-diazatricyclo(6.4.0.0^(2,6))dodeca-1(12),3,5,8,10-pentaen-4-yl)phenyl)urea 结构式
Primary record

3-(5-tert-butyl-1,2-oxazol-3-yl)-1-(4-(10-(2-(morpholin-4-yl)ethoxy)-7-thia-2,5-diazatricyclo(6.4.0.0^(2,6))dodeca-1(12),3,5,8,10-pentaen-4-yl)phenyl)urea

库存
2,740 克
纯度
99.3 %
CAS
950769-58-1

化合物标识与属性

CAS
950769-58-1
PubChem CID
24889392
SMILES
CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3
Canonical SMILES
CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1

名称与同义词

  • Quizartinib
  • 950769-58-1
  • Quizartinib (AC220)
  • AC220
  • quizartinibum
  • vanflyta
  • Quizartinib HCl
  • AC-220
  • Quizartinib freebase
  • AC220 compound
  • AC220,Quizartinib
  • Quizartinib [USAN]
  • Quizartinib, 95%
  • Quizartinib, ac220
  • AC 220
  • Quizartinib (Standard)
  • Quizartinib [USAN:INN]
  • Quizartinib, Free Base
  • quizartinib hydrochloride
  • AC220 - Quizartinib
  • AC 220 dihydrochloride
  • QUIZARTINIB [MI]
  • Quizartinib; PLX3397
  • RefChem:872087
  • 7LA4O6Q0D3
  • QUIZARTINIB [INN]
  • UNII-7LA4O6Q0D3
  • Quizartinib (AC220)?
  • Quizartinib (USAN/INN)
  • Quizartinib dihydrochloride
  • cc-62
  • D07KYT
  • ASP-2689
  • Quizartinib, AC010220
  • AC010220
  • CHEMBL576982
  • ITD 1
  • MFCD18074524
  • SCHEMBL72923
  • QUIZARTINIB [WHO-DD]
  • C29H32N6O4S
  • CHEBI:90217
  • MLS006011240
  • DTXSID70241746
  • AC 010220
  • GTPL5658
  • orb1306579
  • CHEMBL2386811
  • SCHEMBL29349937
  • KS-00000XGC
  • 950769-58-1 (free base)
  • DTXCID00164237
  • L01XE52
  • SYN1003
  • CVWXJKQAOSCOAB-UHFFFAOYSA-N
  • BCPP000443
  • GLXC-90081
  • HMS3244K09
  • HMS3244K10
  • HMS3244L09
  • HMS3265G09
  • HMS3265G10
  • HMS3265H09
  • HMS3265H10
  • HMS3654J20
  • HMS3743G21
  • HMS5079C14
  • AOB87793
  • API01014
  • BCP02224
  • HVB82721
  • AC-010220
  • ABP000304
  • AC220/AC-220
  • BDBM50300690
  • EBC-11441
  • HY-13001R
  • NSC756647
  • NSC799659
  • NSC800857
  • RS0039
  • s1526
  • ZINC43204002
  • AKOS015891557
  • ACN-037466
  • BCP9000223
  • CCG-264906
  • CS-0211
  • DB12874
  • FQ32834
  • NSC-756647
  • NSC-799659
  • NSC-800857
  • SB16610
  • SDCCGSBI-0647186.P001
  • NCGC00242493-01
  • NCGC00242493-02
  • NCGC00242493-07
  • 1-(5-(tert-butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea
  • AK198686
  • AS-16178
  • BC659962
  • BP-44041
  • CID:24889392
  • HY-13001
  • QC-11462
  • SC-85893
  • SMR004703000
  • 1132827-21-4 (HCl)
  • SID:196409687
  • A5793
  • B5858
  • FT-0687630
  • NS00072561
  • SW218131-2
  • V2458
  • J3.116.294G
  • N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea
  • A10027
  • A11124
  • D09955
  • C544967
  • N-(5-tert-Butylisoxazol-3-yl)-N'-[4-[7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
  • Q7272714
  • BRD-K93918653-001-01-4
  • BRD-K93918653-001-08-9
  • I14-17017
  • N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholi
  • 1-METHYLPIPERAZINE-2-CARBOXYLIC ACID DIHYDROCHLORIDE
  • B0084-157290
  • 1-(5-Tert-Butyl-1,2-Oxazol-3-Yl)-3-(4-{7-[2-(Morpholin-4-Yl)ethoxy]imidazo[2,1-B][1,3]benzothiazol-2-Yl}phenyl)urea
  • 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
  • AC-220;AC220;AC 220;950769-58-1
  • N-(5-(1,1-Dimethylethyl)isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-yl)ethoxy)imidazo(2,1-b)benzothiazol-2-yl)phenyl)urea
  • n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea dihydrochloride
  • 1-(5-(tert-Butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)-benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea
  • 1-(5-TERT-BUTYL-1,2-OXAZOL-3-YL)-3-(4-(7-(2-(MORPHOLIN-4-YL)ETHOXY)IMIDAZO(2,1-B)(1,3)BENZOTHIAZOL-2-YL)PHENYL)UREA
  • N-(5-(1,1-Dimethylethyl)isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-yl)ethoxy)imidazo(2,1- b)benzothiazol-2-yl)phenyl)urea
  • Urea, N-(5-(1,1-dimethylethyl)-3-isoxazolyl)-N'-(4-(7-(2-(4-morpholinyl)ethoxy) imidazo(2,1-b)benzothiazol-2-yl)phenyl)-
  • 2-(4-Aminophenyl)-7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b]-[1,3]benzothiazole
  • Quizartinib, 98%, a uniquely potent and selective Flt3 inhibitor - 10MG 10mg
  • 1-(5-tert-butylisoxazol-3-yl)-3-[4-[6-(2-morpholinoethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
  • 1-(5-tert-Butylisoxazole-3-yl)-3-(4-(7-(2-(4-morpholinyl)ethoxy)imidazo[2,1-b]benzothiazole-2-yl)phenyl)urea
  • 1099644-42-4
  • 1132827-21-4
  • 1246550-14-0
  • 3-(5-tert-butyl-1,2-oxazol-3-yl)-1-(4-(10-(2-(morpholin-4-yl)ethoxy)-7-thia-2,5-diazatricyclo(6.4.0.0^(2,6))dodeca-1(12),3,5,8,10-pentaen-4-yl)phenyl)urea
  • 3-(5-tert-butyl-1,2-oxazol-3-yl)-1-(4-(10-(2-(morpholin-4-yl)ethoxy)-7-thia-2,5-diazatricyclo(6.4.0.02,?)dodeca-1(8),3,5,9,11-pentaen-4-yl)phenyl)urea
  • 3-(5-tert-butyl-1,2-oxazol-3-yl)-1-(4-{10-[2-(morpholin-4-yl)ethoxy]-7-thia-2,5-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(12),3,5,8,10-pentaen-4-yl}phenyl)urea
  • 3-(5-tert-butyl-1,2-oxazol-3-yl)-1-(4-{10-[2-(morpholin-4-yl)ethoxy]-7-thia-2,5-diazatricyclo[6.4.0.02,6]dodeca-1(12),3,5,8,10-pentaen-4-yl}phenyl)urea
  • AC 010220; Quizartinib; N-(5-tert-Butylisoxazol-3-yl)-N'-[4-[7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea;
  • N-(5-tert-Butyl-1,2-oxazol-3-yl)-N'-(4-{7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl}phenyl)urea
  • N-(5-tert-Butyl-3-isoxazolyl)-N -[4-[7-(2-morpholinoethoxy)imidazo[2,1-b]benzothiazole-2-yl]phenyl]urea
  • N-(5-tert-Butyl-isoxazol-3-yl)-N''-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea
  • N-(5-Tert-butyl-isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-ylethoxy)imidazo(2,1-b) (1,3)benzothiazol-2-yl)phenyl)urea
  • N-(5-tert-butyl-isoxazol-3-yl)-N'-(4-(7-(2-morpholin-4-yl-ethoxy)imidazo (2,1-b) (1,3) benzothiazol 2-yl)phenyl)urea
  • N-(5-tert-Butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea
  • N-(5-TERT-BUTYLISOXAZOL-3-YL)-N'-(4-(7-(2-(MORPHOLIN-4-YL)ETHOXY)IMIDAZO(2,1-B)(1,3)BENZOTHIAZOL-2-YL)PHENYL)UREA
  • N-(5-TERT-BUTYLISOXAZOL-3-YL)-N'-[4-[7-(2-MORPHOLIN-4-YLETHOXY)IMIDAZO[2,1-B][1,3]BENZOTHIAZOL-2-YL]PHENYL]UREA
  • N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea(Quizartinib)
  • N-[5-(1,1-Dimethylethyl)-3-isoxazolyl]-N'-[4-[7-[2-(4-morpholinyl)ethoxy]imidazo[2,1-b]benzothiazol-2-yl]phenyl]urea
  • p30
  • Urea,N-[5-(1,1-dimethylethyl)-3-isoxazolyl]-N'-[4-[7-[2-(4-morpholinyl)ethoxy]imidazo[2,1-b]benzothiazol-2-yl]phenyl]-